{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T06:45:35Z","timestamp":1768545935489,"version":"3.49.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2008,10,15]],"date-time":"2008-10-15T00:00:00Z","timestamp":1224028800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuropsychopharmacol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1038\/npp.2008.187","type":"journal-article","created":{"date-parts":[[2008,10,16]],"date-time":"2008-10-16T04:57:20Z","timestamp":1224133040000},"page":"1185-1197","source":"Crossref","is-referenced-by-count":68,"title":["A Functional Haplotype Implicated in Vulnerability to Develop Cocaine Dependence is Associated with Reduced PDYN Expression in Human Brain"],"prefix":"10.1038","volume":"34","author":[{"given":"Vadim","family":"Yuferov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orna","family":"Levran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Ho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Morgello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruijin","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jurg","family":"Ott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jeanne","family":"Kreek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,10,15]]},"reference":[{"key":"BFnpp2008187_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0376-8716(98)00071-4","volume":"51","author":"H Akil","year":"1998","unstructured":"Akil H, Owens C, Gutstein H, Taylor L, Curran E, Watson S (1998). Endogenous opioids: overview and current issues. Drug Alcohol Depend 51: 127\u2013140.","journal-title":"Drug Alcohol Depend"},{"key":"BFnpp2008187_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.jneumeth.2007.03.022","volume":"163","author":"M Atz","year":"2007","unstructured":"Atz M, Walsh D, Cartagena P, Li J, Evans S, Choudary P et al (2007). Methodological considerations for gene expression profiling of human brain. J Neurosci Methods 163: 295\u2013309.","journal-title":"J Neurosci Methods"},{"key":"BFnpp2008187_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263\u2013265.","journal-title":"Bioinformatics"},{"key":"BFnpp2008187_CR4","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/0169-328X(92)90178-E","volume":"14","author":"AD Branch","year":"1992","unstructured":"Branch AD, Unterwald EM, Lee SE, Kreek MJ (1992). Quantitation of preproenkephalin mRNA levels in brain regions from male Fischer rats following chronic cocaine treatment using a recently developed solution hybridization assay. Brain Res Mol Brain Res 14: 231\u2013238.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFnpp2008187_CR5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s00439-003-0956-y","volume":"113","author":"NJ Bray","year":"2003","unstructured":"Bray NJ, Buckland PR, Owen MJ, O'Donovan MC (2003). Cis-acting variation in the expression of a high proportion of genes in human brain. Hum Genet 113: 149\u2013153.","journal-title":"Hum Genet"},{"key":"BFnpp2008187_CR6","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1097\/01.ypg.0000218612.35139.84","volume":"16","author":"NJ Bray","year":"2006","unstructured":"Bray NJ, O'Donovan MC (2006). Investigating cis-acting regulatory variation using assays of relative allelic expression. Psychiatr Genet 16: 173\u2013177.","journal-title":"Psychiatr Genet"},{"key":"BFnpp2008187_CR7","doi-asserted-by":"publisher","first-page":"R255","DOI":"10.1093\/hmg\/ddh227","volume":"13","author":"PR Buckland","year":"2004","unstructured":"Buckland PR (2004). Allele-specific gene expression differences in humans. Hum Mol Genet 13: R255\u2013R260.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2008187_CR8","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/ajmg.10362","volume":"114","author":"AC Chen","year":"2002","unstructured":"Chen AC, LaForge KS, Ho A, McHugh PF, Kellogg S, Bell K et al (2002). Potentially functional polymorphism in the promoter region of prodynorphin gene may be associated with protection against cocaine dependence or abuse. Am J Med Genet 114: 429\u2013435.","journal-title":"Am J Med Genet"},{"key":"BFnpp2008187_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1007\/s00439-006-0218-x","volume":"120","author":"JM Chen","year":"2006","unstructured":"Chen JM, F\u00e9rec C, Cooper DN (2006). A systematic analysis of disease-associated variants in the 3\u2032 regulatory regions of human protein-coding genes II: the importance of mRNA secondary structure in assessing the functionality of 3\u2032 UTR variants. Hum Genet 120: 301\u2013333.","journal-title":"Hum Genet"},{"key":"BFnpp2008187_CR10","first-page":"113","volume":"174","author":"LH Claye","year":"1997","unstructured":"Claye LH, Maisonneuve IM, Yu J, Ho A, Kreek MJ (1997). Local perfusion of dynorphin A 1\u201317 reduces extracellular dopamine levels in the nucleus accumbens. NIDA Res Monogr 174: 113.","journal-title":"NIDA Res Monogr"},{"key":"BFnpp2008187_CR11","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/ajmg.b.30238","volume":"139B","author":"JP Dahl","year":"2005","unstructured":"Dahl JP, Weller AE, Kampman KM, Oslin DW, Lohoff FW, Ferraro TN et al (2005). Confirmation of the association between a polymorphism in the promoter region of the prodynorphin gene and cocaine dependence. Am J Med Genet 139B: 106\u2013108.","journal-title":"Am J Med Genet"},{"key":"BFnpp2008187_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/syn.890180106","volume":"18","author":"JB Daunais","year":"1994","unstructured":"Daunais JB, McGinty JF (1994). Acute and chronic cocaine administration differentially alters striatal opioid and nuclear transcription factor mRNAs. Synapse 18: 35\u201345.","journal-title":"Synapse"},{"key":"BFnpp2008187_CR13","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1097\/00001756-199305000-00020","volume":"4","author":"JB Daunais","year":"1993","unstructured":"Daunais JB, Roberts DC, McGinty JF (1993). Cocaine self-administration increases preprodynorphin, but not c-fos, mRNA in rat striatum. Neuroreport 4: 543\u2013546.","journal-title":"Neuroreport"},{"key":"BFnpp2008187_CR14","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1126\/science.1069424","volume":"296","author":"SB Gabriel","year":"2002","unstructured":"Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B et al (2002). The structure of haplotype blocks in the human genome. Science 296: 2225\u20132229.","journal-title":"Science"},{"key":"BFnpp2008187_CR15","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/311461a0","volume":"311","author":"CR Gerfen","year":"1984","unstructured":"Gerfen CR (1984). The neostriatal mosaic: compartmentalization of corticostriatal input and striatonigral output systems. Nature 311: 461\u2013464.","journal-title":"Nature"},{"key":"BFnpp2008187_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/0166-2236(92)90355-C","volume":"15","author":"CR Gerfen","year":"1992","unstructured":"Gerfen CR (1992). The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15: 133\u2013139.","journal-title":"Trends Neurosci"},{"key":"BFnpp2008187_CR17","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/0006-8993(95)00306-B","volume":"681","author":"SD Glick","year":"1995","unstructured":"Glick SD, Maisonneuve IM, Raucci J, Archer S (1995). Kappa opioid inhibition of morphine and cocaine self-administration in rats. Brain Res 681: 147\u2013152.","journal-title":"Brain Res"},{"key":"BFnpp2008187_CR18","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/306611a0","volume":"306","author":"S Horikawa","year":"1983","unstructured":"Horikawa S, Takai T, Toyosato M, Takahashi H, Noda M, Kakidani H et al (1983). Isolation and structural organization of the human preproenkephalin B gene. Nature 306: 611\u2013614.","journal-title":"Nature"},{"key":"BFnpp2008187_CR19","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s00439-007-0453-9","volume":"123","author":"W Huang","year":"2008","unstructured":"Huang W, Ma JZ, Payne TJ, Beuten J, Dupont RT, Li MD (2008). Significant association of DRD1 with nicotine dependence. Hum Genet 123: 133\u2013140.","journal-title":"Hum Genet"},{"key":"BFnpp2008187_CR20","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0306-4522(96)00002-4","volume":"72","author":"YL Hurd","year":"1996","unstructured":"Hurd YL (1996). Differential messenger RNA expression of prodynorphin and proenkephalin in the human brain. Neuroscience 72: 767\u2013783.","journal-title":"Neuroscience"},{"key":"BFnpp2008187_CR21","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/0169-328X(92)90058-J","volume":"13","author":"YL Hurd","year":"1992","unstructured":"Hurd YL, Brown EE, Finlay JM, Fibiger HC, Gerfen CR (1992). Cocaine self-administration differentially alters mRNA expression of striatal peptides. Brain Res Mol Brain Res 13: 165\u2013170.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFnpp2008187_CR22","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/syn.890130408","volume":"13","author":"YL Hurd","year":"1993","unstructured":"Hurd YL, Herkenham M (1993). Molecular alterations in the neostriatum of human cocaine addicts. Synapse 13: 357\u2013369.","journal-title":"Synapse"},{"key":"BFnpp2008187_CR23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/s00109-004-0603-7","volume":"83","author":"JC Knight","year":"2005","unstructured":"Knight JC (2005). Regulatory polymorphisms underlying complex disease traits. J Mol Med 83: 97\u2013109.","journal-title":"J Mol Med"},{"key":"BFnpp2008187_CR24","doi-asserted-by":"publisher","first-page":"1149","DOI":"10.1176\/appi.ajp.2007.05030503","volume":"164","author":"G Koob","year":"2007","unstructured":"Koob G, Kreek MJ (2007). Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 164: 1149\u20131159.","journal-title":"Am J Psychiatry"},{"key":"BFnpp2008187_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.57.1.1","volume":"57","author":"MJ Kreek","year":"2005","unstructured":"Kreek MJ, Bart G, Lilly C, LaForge KS, Nielsen DA (2005). Pharmacogenetics and human molecular genetics of opiate and cocaine addictions and their treatments. Pharmacol Rev 57: 1\u201326.","journal-title":"Pharmacol Rev"},{"key":"BFnpp2008187_CR26","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1038\/nrd897","volume":"1","author":"MJ Kreek","year":"2002","unstructured":"Kreek MJ, LaForge KS, Butelman E (2002). Pharmacotherapy of addictions. Nat Rev Drug Discov 1: 710\u2013726.","journal-title":"Nat Rev Drug Discov"},{"key":"BFnpp2008187_CR27","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0014-2999(98)00637-2","volume":"358","author":"AV Kuzmin","year":"1998","unstructured":"Kuzmin AV, Gerrits MA, Van Ree JM (1998). Kappa-opioid receptor blockade with nor-binaltorphimine modulates cocaine self-administration in drug-naive rats. Eur J Pharmacol 358: 197\u2013202.","journal-title":"Eur J Pharmacol"},{"key":"BFnpp2008187_CR28","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/j.neubiorev.2007.05.008","volume":"31","author":"H Le-Niculescu","year":"2007","unstructured":"Le-Niculescu H, McFarland MJ, Mamidipalli S, Ogden CA, Kuczenski R, Kurian SM et al (2007). Convergent functional genomics of bipolar disorder: from animal model pharmacogenomics to human genetics and biomarkers. Neurosci Biobehav Rev 31: 897\u2013903.","journal-title":"Neurosci Biobehav Rev"},{"key":"BFnpp2008187_CR29","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1111\/j.1601-183X.2008.00410.x","volume":"7","author":"O Levran","year":"2008","unstructured":"Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J et al (2008). Genetic susceptibility to heroin addiction: a candidate\u2013gene association study. Genes Brain Behav 7: 720\u2013729.","journal-title":"Genes Brain Behav"},{"key":"BFnpp2008187_CR30","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1006\/mcne.1994.1015","volume":"5","author":"A Mansour","year":"1994","unstructured":"Mansour A, Fox CA, Meng F, Akil H, Watson SJ (1994). Kappa 1 receptor mRNA distribution in the rat CNS: comparison to kappa receptor binding and prodynorphin mRNA. Mol Cell Neurosci 5: 124\u2013144.","journal-title":"Mol Cell Neurosci"},{"key":"BFnpp2008187_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/0740-5472(92)90062-S","volume":"9","author":"AT McLellan","year":"1992","unstructured":"McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G (1992). The fifth edition of the addiction severity index. J Subst Abuse Treat 9: 199\u2013213.","journal-title":"J Subst Abuse Treat"},{"key":"BFnpp2008187_CR32","unstructured":"Mignone F, Gissi C, Liuni S, Pesole G (2002). Untranslated regions of mRNAs. Genome Biol 3: REVIEWS0004 Epub 2002 February 28."},{"key":"BFnpp2008187_CR33","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nature02797","volume":"430","author":"M Morley","year":"2004","unstructured":"Morley M, Molony CM, Weber TM, Devlin JL, Ewens KG, Spielman RS et al (2004). Genetic analysis of genome-wide variation in human gene expression. Nature 430: 743\u2013747.","journal-title":"Nature"},{"key":"BFnpp2008187_CR34","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S0022-3565(24)36769-2","volume":"282","author":"SS Negus","year":"1997","unstructured":"Negus SS, Mello NK, Portoghese PS, Lin CE (1997). Effects of kappa opioids on cocaine self-administration by rhesus monkeys. J Pharmacol Exp Ther 282: 44\u201355.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008187_CR35","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1038\/sj.mp.4002147","volume":"13","author":"DA Nielsen","year":"2008","unstructured":"Nielsen DA, Ji F, Yuferov V, Ho A, Chen A, Levran O et al (2008). Genotype patterns that contribute to increased risk for or protection from developing heroin addiction. Mol Psychiatry 13: 417\u2013428.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2008187_CR36","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/0165-0173(94)00007-C","volume":"20","author":"A Parent","year":"1995","unstructured":"Parent A, Hazrati LN (1995). Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Brain Res Rev 20: 91\u2013127.","journal-title":"Brain Res Brain Res Rev"},{"key":"BFnpp2008187_CR37","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1093\/hmg\/ddi420","volume":"14","author":"T Pastinen","year":"2005","unstructured":"Pastinen T, Ge B, Gurd S, Gaudin T, Dore C, Lemire M et al (2005). Mapping common regulatory variants to human haplotypes. Hum Mol Genet 14: 3963\u20133971.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2008187_CR38","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1093\/hmg\/ddl044","volume":"15","author":"T Pastinen","year":"2006","unstructured":"Pastinen T, Ge B, Hudson TJ (2006). Influence of human genome polymorphism on gene expression. Hum Mol Genet 15: R9\u2013R16.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2008187_CR39","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1126\/science.1101659","volume":"306","author":"T Pastinen","year":"2004","unstructured":"Pastinen T, Hudson TJ (2004). Cis-acting regulatory variation in the human genome. Science 306: 647\u2013650.","journal-title":"Science"},{"key":"BFnpp2008187_CR40","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1086\/519795","volume":"81","author":"S Purcell","year":"2007","unstructured":"Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D et al (2007). PLINK: a tool set for whole\u2013genome association and population-based linkage analyses. Am J Hum Genet 81: 559\u2013575.","journal-title":"Am J Hum Genet"},{"key":"BFnpp2008187_CR41","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1097\/00041444-200512000-00013","volume":"15","author":"R Ray","year":"2005","unstructured":"Ray R, Doyle GA, Crowley JJ, Buono RJ, Oslin DW, Patkar AA et al (2005). A functional prodynorphin promoter polymorphism and opioid dependence. Psychiatr Genet 15: 295\u2013298.","journal-title":"Psychiatr Genet"},{"key":"BFnpp2008187_CR42","doi-asserted-by":"publisher","first-page":"R207","DOI":"10.1093\/hmg\/ddi261","volume":"14","author":"W Sad\u00e9e","year":"2005","unstructured":"Sad\u00e9e W, Dai Z (2005). Pharmacogenetics\/genomics and personalized medicine. Hum Mol Genet 14: R207\u2013R214.","journal-title":"Hum Mol Genet"},{"key":"BFnpp2008187_CR43","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s002130051016","volume":"144","author":"S Schenk","year":"1999","unstructured":"Schenk S, Partridge B, Shippenberg TS (1999). U69593, a kappa-opioid agonist, decreases cocaine self-administration and decreases cocaine-produced drug-seeking. Psychopharmacology (Berl) 144: 339\u2013346.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008187_CR44","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/S0022-3565(25)22808-7","volume":"250","author":"P Sivam","year":"1989","unstructured":"Sivam P (1989). Cocaine selectively increases striatonigral dynorphin levels by a dopaminergic mechanism. J Pharmacol Exp Ther 250: 818\u2013824.","journal-title":"J Pharmacol Exp Ther"},{"key":"BFnpp2008187_CR45","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/0169-328X(93)90133-A","volume":"19","author":"R Spangler","year":"1993","unstructured":"Spangler R, Unterwald EM, Kreek MJ (1993). \u2018Binge\u2019 cocaine administration induces a sustained increase of prodynorphin mRNA in rat caudate-putamen. Brain Res Mol Brain Res 19: 323\u2013327.","journal-title":"Brain Res Mol Brain Res"},{"key":"BFnpp2008187_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s002210050545","volume":"123","author":"H Steiner","year":"1998","unstructured":"Steiner H, Gerfen CR (1998). Role of dynorphin and enkephalin in the regulation of striatal output pathways and behavior. Exp Brain Res 123: 60\u201376.","journal-title":"Exp Brain Res"},{"key":"BFnpp2008187_CR47","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/1467-9868.00346","volume":"64","author":"JD Storey","year":"2002","unstructured":"Storey JD (2002). A direct approach to false discovery rates. J R Stat Soc, Ser B 64: 479\u2013498.","journal-title":"J R Stat Soc, Ser B"},{"key":"BFnpp2008187_CR48","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.1467-9868.2004.00439.x","volume":"66","author":"DJ Storey","year":"2004","unstructured":"Storey DJ, Taylor JE, Siegmund D (2004). Strong control, conservative point estimation and simultaneous conservative consistency of false discovery rates: a unified approach. J R Stat Soc B 66: 187\u2013205.","journal-title":"J R Stat Soc B"},{"key":"BFnpp2008187_CR49","doi-asserted-by":"publisher","first-page":"9440","DOI":"10.1073\/pnas.1530509100","volume":"100","author":"JD Storey","year":"2003","unstructured":"Storey JD, Tibshirani R (2003). Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100: 9440\u20139445.","journal-title":"Proc Natl Acad Sci USA"},{"key":"BFnpp2008187_CR50","doi-asserted-by":"publisher","first-page":"e93","DOI":"10.1371\/journal.pgen.0020093","volume":"2","author":"H Tao","year":"2006","unstructured":"Tao H, Cox DR, Frazer KA (2006). Allele-specific KRT1 expression is a complex trait. PLoS Genet 2: e93.","journal-title":"PLoS Genet"},{"key":"BFnpp2008187_CR51","doi-asserted-by":"publisher","first-page":"6583","DOI":"10.1523\/JNEUROSCI.1544-06.2006","volume":"26","author":"ND Volkow","year":"2006","unstructured":"Volkow ND, Wang GJ, Telang F, Fowler JS, Logan J, Childress AR et al (2006). Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction. J Neurosci 26: 6583\u20136588.","journal-title":"J Neurosci"},{"key":"BFnpp2008187_CR52","doi-asserted-by":"crossref","unstructured":"Wang JC, Grucza R, Cruchaga C, Hinrichs AL, Bertelsen S, Budde JP et al (2008). Genetic variation in the CHRNA5 gene affects mRNA levels and is associated with risk for alcohol dependence. Mol Psychiatry (15 April), doi: 10.1038\/mp.2008.42, PMID: 18414406. [E-pub ahead of print].","DOI":"10.1038\/mp.2008.42"},{"key":"BFnpp2008187_CR53","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1111\/j.1369-1600.2007.00069.x","volume":"12","author":"TJ Williams","year":"2007","unstructured":"Williams TJ, LaForge KS, Gordon D, Bart G, Kellogg S, Ott J et al (2007). Prodynorphin gene promoter repeat associated with cocaine\/alcohol codependence. Addict Biol 12: 496\u2013502.","journal-title":"Addict Biol"},{"key":"BFnpp2008187_CR54","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nature03441","volume":"434","author":"X Xie","year":"2005","unstructured":"Xie X, Lu J, Kulbokas EJ, Golub TR, Mootha V, Lindblad-Toh K et al (2005). Systematic discovery of regulatory motifs in human promoters and 3\u2032 UTRs by comparison of several mammals. Nature 434: 338\u2013345.","journal-title":"Nature"},{"key":"BFnpp2008187_CR55","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1038\/sj.mp.4001882","volume":"11","author":"X Xuei","year":"2006","unstructured":"Xuei X, Dick D, Flury-Wetherill L, Tian HJ, Agrawal A, Bierut L et al (2006). Association of the kappa-opioid system with alcohol dependence. Mol Psychiatry 11: 1016\u20131024.","journal-title":"Mol Psychiatry"},{"key":"BFnpp2008187_CR56","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1126\/science.1072545","volume":"297","author":"H Yan","year":"2002","unstructured":"Yan H, Yuan W, Velculescu VE, Vogelstein B, Kinzler KW (2002). Allelic variation in human gene expression. Science 297: 1143.","journal-title":"Science"},{"key":"BFnpp2008187_CR57","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0361-9230(01)00496-8","volume":"55","author":"V Yuferov","year":"2001","unstructured":"Yuferov V, Zhou Y, LaForge KS, Spangler R, Ho A, Kreek MJ (2001). Elevation of guinea pig brain preprodynorphin mRNA expression and hypothalamic-pituitary-adrenal axis activity by \u2018binge\u2019 pattern cocaine administration. Brain Res Bull 55: 65\u201370.","journal-title":"Brain Res Bull"},{"key":"BFnpp2008187_CR58","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1007\/s00213-003-1688-3","volume":"172","author":"Y Zhang","year":"2004","unstructured":"Zhang Y, Butelman ER, Schlussman SD, Ho A, Kreek MJ (2004). Effect of the endogenous kappa opioid agonist dynorphin A(1\u201317) on cocaine-evoked increases in striatal dopamine levels and cocaine-induced place preference in C57BL\/6J mice. Psychopharmacology (Berl) 172: 422\u2013429.","journal-title":"Psychopharmacology (Berl)"},{"key":"BFnpp2008187_CR59","doi-asserted-by":"publisher","first-page":"32618","DOI":"10.1074\/jbc.M504942200","volume":"280","author":"Y Zhang","year":"2005","unstructured":"Zhang Y, Wang D, Johnson AD, Papp AC, Sad\u00e9e W (2005). Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G. J Biol Chem 280: 32618\u201332624.","journal-title":"J Biol Chem"},{"key":"BFnpp2008187_CR60","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1046\/j.1471-4159.2000.740472.x","volume":"74","author":"A Zimprich","year":"2000","unstructured":"Zimprich A, Kraus J, Woltje M, Mayer P, Rauch E, H\u00f6llt V (2000). An allelic variation in the human prodynorphin gene promoter alters stimulus induced expression. J Neurochem 74: 472\u2013477.","journal-title":"J Neurochem"}],"container-title":["Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/npp2008187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008187","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/npp2008187.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T22:27:00Z","timestamp":1738448820000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/npp2008187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10,15]]},"references-count":60,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["BFnpp2008187"],"URL":"https:\/\/doi.org\/10.1038\/npp.2008.187","relation":{},"ISSN":["0893-133X","1740-634X"],"issn-type":[{"value":"0893-133X","type":"print"},{"value":"1740-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,10,15]]}}}